These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28890316)

  • 1. Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer's Disease.
    Telling ND; Everett J; Collingwood JF; Dobson J; van der Laan G; Gallagher JJ; Wang J; Hitchcock AP
    Cell Chem Biol; 2017 Oct; 24(10):1205-1215.e3. PubMed ID: 28890316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-β Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer's Disease Mouse Model.
    Seo SJ; Chang WS; Jeon JG; Choi Y; Kim E; Kim JK
    J Alzheimers Dis; 2021; 84(1):377-392. PubMed ID: 34569962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
    Everett J; Collingwood JF; Tjendana-Tjhin V; Brooks J; Lermyte F; Plascencia-Villa G; Hands-Portman I; Dobson J; Perry G; Telling ND
    Nanoscale; 2018 Jul; 10(25):11782-11796. PubMed ID: 29688240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacitive Electrode-Based Electric Field Treatments on Redox-Toxic Iron Deposits in Transgenic AD Mouse Models: The Electroceutical Targeting of Alzheimer's Disease Feasibility Study.
    Choi Y; Lee WS; Lee J; Park SH; Kim S; Kim KH; Park S; Kim EH; Kim JK
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid.
    Everett J; Céspedes E; Shelford LR; Exley C; Collingwood JF; Dobson J; van der Laan G; Jenkins CA; Arenholz E; Telling ND
    Inorg Chem; 2014 Mar; 53(6):2803-9. PubMed ID: 24559299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42).
    Everett J; Céspedes E; Shelford LR; Exley C; Collingwood JF; Dobson J; van der Laan G; Jenkins CA; Arenholz E; Telling ND
    J R Soc Interface; 2014 Jun; 11(95):20140165. PubMed ID: 24671940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.
    Miller LM; Wang Q; Telivala TP; Smith RJ; Lanzirotti A; Miklossy J
    J Struct Biol; 2006 Jul; 155(1):30-7. PubMed ID: 16325427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues.
    Everett J; Brooks J; Tjendana Tjhin V; Lermyte F; Hands-Portman I; Plascencia-Villa G; Perry G; Sadler PJ; O'Connor PB; Collingwood JF; Telling ND
    ACS Chem Neurosci; 2024 Apr; 15(7):1469-1483. PubMed ID: 38501754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.
    Peters DG; Connor JR; Meadowcroft MD
    Neurobiol Dis; 2015 Sep; 81():49-65. PubMed ID: 26303889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
    Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
    Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
    Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
    Michno W; Wehrli PM; Zetterberg H; Blennow K; Hanrieder J
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):458-467. PubMed ID: 30273679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic implications of gelsolin in Alzheimer's disease.
    Ji L; Zhao X; Hua Z
    J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.